Structural, mutagenic, and kinetic analysis of the binding of substrates and inhibitors of human phenylethanolamine N-methyltransferase


Autoria(s): Wu, Q.; Gee, C. L.; Lin, F.; Tyndall, J. D.; Martin, J. L.; Grunewald, G. L.; McLeish, M. J.
Data(s)

01/01/2005

Resumo

The X-ray structure of human phenylethanolamine N-methyltransferase (hPNMT) complexed. with its product, S-adenoSyl-L-homocysteine (4), and the most potent inhibitor reported to date, SK&F 64139 (7), was used to identify the residues involved in inhibitor binding. Four of these residues, Va153, Lys57, Glu219 and Asp267, were replaced, in turn, with alanine. All variants had increased K-m values for phenylethanolamine (10), but only D267A showed a noteworthy (20-fold) decrease in its k(cat) value. Both WT hPNMT and D267A had similar k(cat) values for a rigid analogue, anti-9-amino-6-(trifluoromethyl)benzonorbornene (12), suggesting that Asp267 plays an important role in positioning the substrate but does not participate directly in catalysis. The K-i values for the binding of inhibitors such as 7 to the E219A and D267A variants increased by 2-3 orders of magnitude. Further, the inhibitors were shown to bind up to 50-fold more tightly in the presence of S-adenoSyl-(L)-methionine (3), suggesting that the binding of the latter brings about a conformational change in the enzyme.

Identificador

http://espace.library.uq.edu.au/view/UQ:77629

Idioma(s)

eng

Publicador

American Chemical Society

Palavras-Chave #Chemistry, Medicinal #Defined Adrenergic Agents #Methyl Transferase #Selective Inhibitors #Crystal-structures #F 29661 #S-adenosylhomocysteine #Biochemical Evaluation #Catalytic Mechanism #Active-site #Alpha(2)-adrenoceptor #C1 #270108 Enzymes #780105 Biological sciences
Tipo

Journal Article